Publications by authors named "Alan R Olzinski"

Claim this Profile
D
Development of an LC-MS/MS assay for quantification of intact INSL3 in rat plasma.
Nicole A Schneck, Lela Mortezavi, Alan R Olzinski, Diane Posavec, Larry J Jolivette

Bioanalysis· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activation of the Amino Acid Response Pathway Blunts the Effects of Cardiac Stress.
Pu Qin, Pelin Arabacilar, Roberta E Bernard, Weike Bao, Alan R Olzinski

J Am Heart Assoc· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Soluble epoxide hydrolase inhibition does not prevent cardiac remodeling and dysfunction after aortic constriction in rats and mice.
Lisa A Morgan, Alan R Olzinski, John J Upson, Shufang Zhao, Tao Wang

J Cardiovasc Pharmacol· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of soluble guanylate cyclase stimulators and activators in models of cardiovascular disease associated with oxidative stress.
Melissa H Costell, Nicolas Ancellin, Roberta E Bernard, Shufang Zhao, John J Upson, Alan R Olzinski

Front Pharmacol· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic inhibition of hypoxia-inducible factor prolyl 4-hydroxylase improves ventricular performance, remodeling, and vascularity after myocardial infarction in the rat.
Weike Bao, Pu Qin, Saul Needle, Connie L Erickson-Miller, Kevin J Duffy, Alan R Olzinski

J Cardiovasc Pharmacol· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological inhibition of C-C chemokine receptor 2 decreases macrophage infiltration in the aortic root of the human C-C chemokine receptor 2/apolipoprotein E-/- mouse: magnetic resonance imaging assessment.
Alan R Olzinski, Gregory H Turner, Roberta E Bernard, Heather Karr, Carla A Cornejo

Arterioscler Thromb Vasc Biol· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential effects of p38 mitogen-activated protein kinase and cyclooxygenase 2 inhibitors in a model of cardiovascular disease.
Robert N Willette, Marianne E Eybye, Alan R Olzinski, David J Behm, Nambi Aiyar

J Pharmacol Exp Ther· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of macrophage infiltration in a murine model of abdominal aortic aneurysm.
Gregory H Turner, Alan R Olzinski, Roberta E Bernard, Karpagam Aravindhan, Ryan J Boyle

J Magn Reson Imaging· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo serial assessment of aortic aneurysm formation in apolipoprotein E-deficient mice via MRI.
Gregory H Turner, Alan R Olzinski, Roberta E Bernard, Karpagam Aravindhan, Heather W Karr

Circ Cardiovasc Imaging· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
p38 MAPK inhibition reduces aortic ultrasmall superparamagnetic iron oxide uptake in a mouse model of atherosclerosis: MRI assessment.
Joanne B Morris, Alan R Olzinski, Roberta E Bernard, Karpagam Aravindhan, Rosanna C Mirabile

Arterioscler Thromb Vasc Biol· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective PPARdelta agonist treatment increases skeletal muscle lipid metabolism without altering mitochondrial energy coupling: an in vivo magnetic resonance spectroscopy study.
Beat M Jucker, Dewen Yang, Warren M Casey, Alan R Olzinski, Carolyn Williams

Am J Physiol Endocrinol Metab· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PPARdelta activation normalizes cardiac substrate metabolism and reduces right ventricular hypertrophy in congestive heart failure.
Beat M Jucker, Christopher P Doe, Christine G Schnackenberg, Alan R Olzinski, Kristeen Maniscalco

J Cardiovasc Pharmacol· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypertensive target organ damage is attenuated by a p38 MAPK inhibitor: role of systemic blood pressure and endothelial protection.
Alan R Olzinski, Tara A McCafferty, Shufang Q Zhao, David J Behm, Marianne E Eybye

Cardiovasc Res· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential uptake of ferumoxtran-10 and ferumoxytol, ultrasmall superparamagnetic iron oxide contrast agents in rabbit: critical determinants of atherosclerotic plaque labeling.
April D Yancy, Alan R Olzinski, Tom C-C Hu, Stephen C Lenhard, Karpagam Aravindhan

J Magn Reson Imaging· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cathepsin S expression is up-regulated following balloon angioplasty in the hypercholesterolemic rabbit.
Cynthia L Burns-Kurtis, Alan R Olzinski, Saul Needle, Josephine H Fox, Elizabeth A Capper

Cardiovasc Res· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
p38 MAPK inhibitors ameliorate target organ damage in hypertension: Part 1. p38 MAPK-dependent endothelial dysfunction and hypertension.
Haisong Ju, David J Behm, Sandyha Nerurkar, Marianne E Eybye, Robin E Haimbach, Alan R Olzinski

J Pharmacol Exp Ther· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained activation of p38 mitogen-activated protein kinase contributes to the vascular response to injury.
Haisong Ju, Sandhya Nerurkar, Charles F Sauermelch, Alan R Olzinski, Rosanna Mirabile

J Pharmacol Exp Ther· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis